Systemic calciphylaxis

Manika Suryadevara, Scott J. Schurman, Steve K. Landas, Abraham Philip, Christopher B. Gerlach, Trisha Tavares, Abdul Kader Souid

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


An 11-year-old male developed systemic calciphylaxis during induction therapy for acute lymphoblastic leukemia. His predisposing conditions were hypercalcemia, supplements for pamidronate-induced hypocalcemia and hypophosphatemia and renal insufficiency. He died of cardiorespiratory arrest on the 20th day of induction treatment. Autopsy revealed extensive calcium deposits in the heart, lungs and kidneys. He had diffused alveolar damage, acute tubular necrosis, chronic pancreatitis and marked hepatic steatosis. Systemic calcium deposition may progress rapidly in children with hypercalcemia of malignancy. Since Pamidronate reduces mineral resorption from tissues, calcium and phosphate replacements increase systemic mineral deposits. Thus, mineral supplements should be considered only to combat symptoms.

Original languageEnglish
Pages (from-to)548-550
Number of pages3
JournalPediatric Blood and Cancer
Issue number4
Publication statusPublished - Oct 2008
Externally publishedYes


  • Calciphylaxis
  • Hypercalcemia
  • Leukemia
  • Pamidronate

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Systemic calciphylaxis'. Together they form a unique fingerprint.

Cite this